中國太平(00966.HK)附屬公司太平養老獲富傑增資10.75億元
格隆匯5月20日丨中國太平(00966.HK)宣佈,2024年5月20日,公司、龍璧、富傑及太平養老訂立增資協議。根據增資協議,富傑同意有條件認購,而太平養老同意有條件發行相當於太平養老擴大後的已發行股本約10%的認購股份,以人民幣10.75億元為對價。本次增資完成後,在太平養老經本次增資擴大後的已發行股本中,約90%由公司持有,約10%由富傑持有。太平養老將為公司非全資附屬公司。
根據股東協議,在股東協議簽署日後至交割之日的第3個週年日止的任何時間,富傑有權選擇通過隨時和不時一次性或分多次行權,自行認購或提名其一家或多家符合法律的附屬公司認購太平養老將發行的某一數量的股份,從而將富傑及其附屬公司的持股比例最高增至(含)24.99%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.